PL3165523T3 - Kompozycja do indukowania przeprogramowania komórek - Google Patents
Kompozycja do indukowania przeprogramowania komórekInfo
- Publication number
- PL3165523T3 PL3165523T3 PL15815352T PL15815352T PL3165523T3 PL 3165523 T3 PL3165523 T3 PL 3165523T3 PL 15815352 T PL15815352 T PL 15815352T PL 15815352 T PL15815352 T PL 15815352T PL 3165523 T3 PL3165523 T3 PL 3165523T3
- Authority
- PL
- Poland
- Prior art keywords
- composition
- inducing cell
- cell reprogramming
- reprogramming
- inducing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1323—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from skeletal muscle cells
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140081889A KR101731624B1 (ko) | 2014-07-01 | 2014-07-01 | 세포 리프로그래밍 유도용 조성물 |
PCT/KR2015/006718 WO2016003169A2 (ko) | 2014-07-01 | 2015-06-30 | 세포 리프로그래밍 유도용 조성물 |
EP15815352.8A EP3165523B1 (en) | 2014-07-01 | 2015-06-30 | Composition for inducing cell reprogramming |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3165523T3 true PL3165523T3 (pl) | 2020-07-13 |
Family
ID=55020061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL15815352T PL3165523T3 (pl) | 2014-07-01 | 2015-06-30 | Kompozycja do indukowania przeprogramowania komórek |
Country Status (8)
Country | Link |
---|---|
US (1) | US10858321B2 (pl) |
EP (1) | EP3165523B1 (pl) |
JP (1) | JP6511075B2 (pl) |
KR (1) | KR101731624B1 (pl) |
CN (1) | CN106794172B (pl) |
ES (1) | ES2768803T3 (pl) |
PL (1) | PL3165523T3 (pl) |
WO (1) | WO2016003169A2 (pl) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20240076059A (ko) | 2022-11-23 | 2024-05-30 | 동서대학교 산학협력단 | 리버신을 유효성분으로 포함하는 아토피 예방, 개선 또는 치료용 조성물 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5244907A (en) * | 1992-03-26 | 1993-09-14 | A. H. Robins Company, Incorporated | Carbocyclic carboxylic acid amides and esters of azabicyclic compounds as gastric prokinetic, antiemetic, anxiolytic and antiarrhythmic agents |
JP3289177B2 (ja) * | 1995-07-07 | 2002-06-04 | コニカ株式会社 | 新規な写真用カプラー及びハロゲン化銀カラー写真感光材料 |
DE19810018A1 (de) * | 1998-03-09 | 1999-09-16 | Bayer Ag | Benzoheterocyclyloxime |
US7642278B2 (en) * | 2001-07-03 | 2010-01-05 | Novartis Vaccines And Diagnostics, Inc. | Indazole benzimidazole compounds |
US6897208B2 (en) * | 2001-10-26 | 2005-05-24 | Aventis Pharmaceuticals Inc. | Benzimidazoles |
TW200306819A (en) * | 2002-01-25 | 2003-12-01 | Vertex Pharma | Indazole compounds useful as protein kinase inhibitors |
FR2836915B1 (fr) * | 2002-03-11 | 2008-01-11 | Aventis Pharma Sa | Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
DK1532145T3 (da) * | 2002-08-02 | 2007-01-15 | Vertex Pharma | Pyrazolpræparater der er anvendelige som inhibitorer af GSK-3 |
JP2006502133A (ja) * | 2002-08-10 | 2006-01-19 | アステックス、セラピューティックス、リミテッド | サイクリン依存キナーゼ(cdk)インヒビターとしての3−(カルボニル)1h−インダゾール化合物 |
FR2845382A1 (fr) | 2002-10-02 | 2004-04-09 | Sanofi Synthelabo | Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique |
MXPA06010852A (es) * | 2004-03-25 | 2007-01-16 | Memory Pharm Corp | Indazoles, benzotiazoles, benzoisotiazoles, bencisoxazoles y preparacion y usos de los mismos. |
DE102004028862A1 (de) * | 2004-06-15 | 2005-12-29 | Merck Patent Gmbh | 3-Aminoindazole |
JP5255559B2 (ja) * | 2006-03-31 | 2013-08-07 | アボット・ラボラトリーズ | インダゾール化合物 |
JP2010509231A (ja) * | 2006-11-02 | 2010-03-25 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼの阻害剤として有用なアミノピリジンおよびアミノピリミジン |
US20080194557A1 (en) * | 2007-01-18 | 2008-08-14 | Joseph Barbosa | Methods and compositions for the treatment of pain, inflammation and cancer |
JP5506674B2 (ja) * | 2007-07-20 | 2014-05-28 | ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ | キナーゼ阻害剤として活性な置換インダゾール誘導体 |
EP2464231A4 (en) * | 2009-08-10 | 2013-02-06 | Samumed Llc | INDAZOLE AS WNT / B-CATENINE SIGNALING PATHWASHER AND THERAPEUTIC APPLICATIONS THEREOF |
JP5982286B2 (ja) * | 2009-10-31 | 2016-08-31 | ニュー・ワールド・ラボラトリーズ・インコーポレイテッドNew World Laboratories Inc. | 細胞の再プログラミングのための方法とその用途 |
CA2815169C (en) * | 2010-10-29 | 2015-10-06 | Pfizer Inc. | N1/n2-lactam acetyl-coa carboxylase inhibitors |
MX362940B (es) * | 2011-12-28 | 2019-02-27 | Fujifilm Corp | Nuevo derivado de nicotinamida o la sal del mismo. |
KR101539132B1 (ko) * | 2012-01-20 | 2015-07-28 | 주식회사 스템랩 | 유전자 도입 없이 저분자성 물질을 이용하여 체세포로부터 심근세포를 유도하는 방법 |
US20130281399A1 (en) * | 2012-04-19 | 2013-10-24 | Rvx Therapeutics Inc. | Treatment of diseases by epigenetic regulation |
CA2921880A1 (en) * | 2013-08-22 | 2015-02-26 | F. Hoffmann-La Roche Ag | Alkynyl alcohols and methods of use |
EP3183239B1 (en) * | 2014-08-22 | 2018-09-26 | Merck Patent GmbH | Indazoles |
-
2014
- 2014-07-01 KR KR1020140081889A patent/KR101731624B1/ko active IP Right Grant
-
2015
- 2015-06-30 PL PL15815352T patent/PL3165523T3/pl unknown
- 2015-06-30 ES ES15815352T patent/ES2768803T3/es active Active
- 2015-06-30 US US15/323,342 patent/US10858321B2/en active Active
- 2015-06-30 EP EP15815352.8A patent/EP3165523B1/en active Active
- 2015-06-30 CN CN201580036120.XA patent/CN106794172B/zh not_active Expired - Fee Related
- 2015-06-30 JP JP2016575756A patent/JP6511075B2/ja active Active
- 2015-06-30 WO PCT/KR2015/006718 patent/WO2016003169A2/ko active Application Filing
Also Published As
Publication number | Publication date |
---|---|
KR101731624B1 (ko) | 2017-05-04 |
KR20160003965A (ko) | 2016-01-12 |
JP6511075B2 (ja) | 2019-05-15 |
CN106794172A (zh) | 2017-05-31 |
EP3165523A4 (en) | 2017-08-30 |
ES2768803T3 (es) | 2020-06-23 |
WO2016003169A2 (ko) | 2016-01-07 |
JP2017526342A (ja) | 2017-09-14 |
EP3165523B1 (en) | 2020-01-08 |
US20170158642A1 (en) | 2017-06-08 |
CN106794172B (zh) | 2020-03-17 |
EP3165523A2 (en) | 2017-05-10 |
WO2016003169A3 (ko) | 2016-06-16 |
US10858321B2 (en) | 2020-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL274903A (en) | cell | |
ZA201901336B (en) | Improved t cell compositions | |
SG10202005876VA (en) | Cell reprogramming | |
SG10202000644TA (en) | Improved Stem Cell Composition | |
GB201410905D0 (en) | Composition | |
GB201404178D0 (en) | Composition | |
GB201403017D0 (en) | Composition | |
GB201414910D0 (en) | Composition | |
GB201403561D0 (en) | Composition | |
GB201414555D0 (en) | Composition | |
GB201410493D0 (en) | Composition | |
HUE042287T2 (hu) | Lítium-kén cella | |
PL3165523T3 (pl) | Kompozycja do indukowania przeprogramowania komórek | |
GB201420628D0 (en) | Composition | |
GB201415483D0 (en) | Composition | |
GB201404390D0 (en) | Composition | |
GB201403550D0 (en) | Composition | |
GB201402648D0 (en) | Composition | |
GB201410934D0 (en) | T cell | |
GB201421660D0 (en) | Composition | |
GB201420629D0 (en) | Composition | |
GB201412414D0 (en) | Composition | |
GB201412314D0 (en) | Composition | |
GB201402487D0 (en) | Composition | |
GB201401510D0 (en) | Composition |